Tag | Content |
---|
EnhancerAtlas ID | HS098-54198 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr8:22382700-22384750 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr8:22384651-22384672 | CCAAAGTTTCAGTTTCTTTTG | + | 6.11 | IRF1 | MA0050.2 | chr8:22382972-22382993 | CTTTTCTTTCTTTTTCTTTCT | + | 6.3 | IRF1 | MA0050.2 | chr8:22382921-22382942 | CTCTTCTTTCTCTTTCTCTCT | + | 6.68 | IRF8 | MA0652.1 | chr8:22384655-22384669 | AGTTTCAGTTTCTT | - | 6.03 | IRF9 | MA0653.1 | chr8:22384655-22384670 | AGTTTCAGTTTCTTT | - | 7.05 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_11137 | chr8:22380596-22391184 | CD20 | SE_27805 | chr8:22383948-22385299 | Fetal_Intestine |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH08I022526 | chr8 | 22384096 | 22385214 |
|
Enhancer Sequence | TACCTGAGTA TTCTGTCGGC TTTGACATAA TTAGTAACTT TTATCTCAAA ACAGTCTTAT 60 TTTCATTGGT TGTTTCTTAG GCATTTTAGA AGGAAAAAGG CAGAAAATGT GGCATTTGAA 120 ACAGTCCCTG GGGGTACTCA GTTACTCCCC ATACAAGTGC CTTCTTTTCT GAAAAAGGGA 180 ACTCTATTAT TCTTTTTCTT CTTCCTTTTC TTCTACTGTT GCTCTTCTTT CTCTTTCTCT 240 CTTTTCTTTT CTCTCTCTTT CTCTCTCTCT TTCTTTTCTT TCTTTTTCTT TCTGCTTCCT 300 TTTCTTCTTT CTTTCTTTCT TTCTTTCTTT CTTTCTTTCT TTCTTTCTTT CTCTCCCTCT 360 CTCTCTCTCT CTTTCTTTCT CTCTCTCTCT CTTTCTCTCG GTCTCTGTCA CTTAGGTTGG 420 AGCACAGTGG CAGGAACTTG ATTCACTGCA GCCTCGACTT CCTGGGCTCA AGTGATCCTC 480 CCACCTCAGC CTCCCAACTA GCTGGGACCA CAGGTGCATG CCGCTACACC TGGCTAATTT 540 TAAAATATTT TTTATAGAGA TAGGGTCTCG TTATGTTGCC CAGACTGGTC TCAAACTCCT 600 GAGCTTAAGC AGTCCTCCTG CCTCGGCCTC CCAAAGTGCT GGTATTACAA GTGTGTGCCA 660 CCACACCTGG CCTCTTTCAT ATTATTTTTT TTTTTTCAGA GACAGAGTCT CACTGTGTTG 720 CCCAGGCTGG AGTGCAGTGG TGCGGTCTTG GCTCACTACA ACCTCTGCCT CCCGGGTTCA 780 AGCAATTCTC CCGCCTCAGC CTCCCGAGTA GCTGGGACTA CAGGTGCACG TCGCCACGCC 840 TGGCTAATTT TTTTTATTTT AGTAGAGACG GGGTTTTACC ATGTTGCCCA GGCTGGTCTC 900 AATCTCCTGA GCTCAGGCAA TCTGCCCACC TCGGCCTCCC AAAGTGCTAG GAGTGCTCTT 960 TCATATTCTT TAGACTTCTT GGTATCTACA GGTATTTCCT AGTTCCACTA GTTACACGAA 1020 AGACCTTTAA TCATGATTTT TAAAGATTCT TATTCTTGTT TTCTTCTGTC CACTGGGAAC 1080 ACACCCAAAA GCAGTTTTAT AAGCTCTTGT TTCCAGTCAT TCACTGTTGA GACTCACCTC 1140 CCACTTCTTT TTCCTGGGTA GAAATTGAGG GAGTTGTTGA ATAATGATAT ATGACATATT 1200 TACCTAAACT AAATAAAATA CATACACGTG AAAATAATGG AACATGTACA TCATAGCCAG 1260 TGTTAGGCTT TTTAAGTGCT AGAAACTATA TTTTAATTTA TTTTCTTAAT AATATATGGT 1320 GTACATTTTA GACATTCAAT AACTTAAATT TTAAGAACAC TAGATTATCC TGTAGCAAAG 1380 AAACAGGAAT GAGGACGTGA CCTATATCTG TCATTTCTGG AGAACTGTTA CACCCTGTTT 1440 TATTTTATGA CCACAGAATA ATTAAGAGAA TAGTGCAAAC AACATTGCTG GTGATAAAGG 1500 CTAAGGAATT GGATTTTAAG ACTTTCAAAA TATAAAGAAA ATCAGTTTGG CATCAAAGTA 1560 TGTGTGCGAC TATCTGAATG GTTAATATTA AACATAGCAT GCTGGCAATA CACTGCTGTG 1620 TATTGGAGAA ATCGGCAATT TTAAAATCCG CTATATTGAA TACAGAGATG ACTTAATCTA 1680 ATTTTGAACA TTTAATTGTA AATTGCTCCA AGTTTGCCAT TTGTATCTTC CAGTATGAGT 1740 TGATAACTGC AATATATAAA CTCCCAGAGA GTGTATACAA TCTTTGACTC TGGCTAATGA 1800 CTAGCAAAAC AGGCTGTGTC CATTTAATGA GTAATTTTTG CCTTCAAAGG AGAGTTGTAA 1860 TTATAACCAT TTGGCCTATA AAAGGAAATT ATGGGGAAAT TTTCCTCACG TGGATCTTGA 1920 GGTTTATATA GATAGTTACT GTGCAGTGAC TCCAAAGTTT CAGTTTCTTT TGTACTTTTA 1980 TTATATGAGC TCTTCAGGTA ACTTTGTTCC TTGGAATAAT TCTTAAGAGA ATGAACTGAA 2040 TAAAAGGCTT 2050
|